Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11972391rdf:typepubmed:Citationlld:pubmed
pubmed-article:11972391lifeskim:mentionsumls-concept:C1140680lld:lifeskim
pubmed-article:11972391lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:11972391lifeskim:mentionsumls-concept:C2347026lld:lifeskim
pubmed-article:11972391lifeskim:mentionsumls-concept:C0370003lld:lifeskim
pubmed-article:11972391lifeskim:mentionsumls-concept:C0178539lld:lifeskim
pubmed-article:11972391lifeskim:mentionsumls-concept:C0017817lld:lifeskim
pubmed-article:11972391lifeskim:mentionsumls-concept:C0054252lld:lifeskim
pubmed-article:11972391lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:11972391lifeskim:mentionsumls-concept:C1441547lld:lifeskim
pubmed-article:11972391lifeskim:mentionsumls-concept:C1709059lld:lifeskim
pubmed-article:11972391lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:11972391lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:11972391lifeskim:mentionsumls-concept:C1550605lld:lifeskim
pubmed-article:11972391lifeskim:mentionsumls-concept:C0456205lld:lifeskim
pubmed-article:11972391pubmed:issue2lld:pubmed
pubmed-article:11972391pubmed:dateCreated2002-4-25lld:pubmed
pubmed-article:11972391pubmed:abstractTextThe objective was to assess the relationship between glutathione content and drug sensitivity with glutathione modulation in ovarian cancer in a pilot study using 31 samples of freshly obtained ovarian tumor material from 26 patients with advanced disease.lld:pubmed
pubmed-article:11972391pubmed:languageenglld:pubmed
pubmed-article:11972391pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11972391pubmed:citationSubsetIMlld:pubmed
pubmed-article:11972391pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11972391pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11972391pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11972391pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11972391pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11972391pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11972391pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11972391pubmed:statusMEDLINElld:pubmed
pubmed-article:11972391pubmed:monthMaylld:pubmed
pubmed-article:11972391pubmed:issn0090-8258lld:pubmed
pubmed-article:11972391pubmed:authorpubmed-author:LewandowiczGr...lld:pubmed
pubmed-article:11972391pubmed:authorpubmed-author:BrittPaulPlld:pubmed
pubmed-article:11972391pubmed:authorpubmed-author:ElgieAlena...lld:pubmed
pubmed-article:11972391pubmed:authorpubmed-author:WilliamsonChr...lld:pubmed
pubmed-article:11972391pubmed:authorpubmed-author:ColeyHelen...lld:pubmed
pubmed-article:11972391pubmed:authorpubmed-author:HallAndrew...lld:pubmed
pubmed-article:11972391pubmed:authorpubmed-author:SargentJean...lld:pubmed
pubmed-article:11972391pubmed:copyrightInfo(c) 2002 Elsevier Science (USA).lld:pubmed
pubmed-article:11972391pubmed:issnTypePrintlld:pubmed
pubmed-article:11972391pubmed:volume85lld:pubmed
pubmed-article:11972391pubmed:ownerNLMlld:pubmed
pubmed-article:11972391pubmed:authorsCompleteYlld:pubmed
pubmed-article:11972391pubmed:pagination298-304lld:pubmed
pubmed-article:11972391pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11972391pubmed:meshHeadingpubmed-meshheading:11972391...lld:pubmed
pubmed-article:11972391pubmed:meshHeadingpubmed-meshheading:11972391...lld:pubmed
pubmed-article:11972391pubmed:meshHeadingpubmed-meshheading:11972391...lld:pubmed
pubmed-article:11972391pubmed:meshHeadingpubmed-meshheading:11972391...lld:pubmed
pubmed-article:11972391pubmed:meshHeadingpubmed-meshheading:11972391...lld:pubmed
pubmed-article:11972391pubmed:meshHeadingpubmed-meshheading:11972391...lld:pubmed
pubmed-article:11972391pubmed:meshHeadingpubmed-meshheading:11972391...lld:pubmed
pubmed-article:11972391pubmed:meshHeadingpubmed-meshheading:11972391...lld:pubmed
pubmed-article:11972391pubmed:meshHeadingpubmed-meshheading:11972391...lld:pubmed
pubmed-article:11972391pubmed:meshHeadingpubmed-meshheading:11972391...lld:pubmed
pubmed-article:11972391pubmed:meshHeadingpubmed-meshheading:11972391...lld:pubmed
pubmed-article:11972391pubmed:meshHeadingpubmed-meshheading:11972391...lld:pubmed
pubmed-article:11972391pubmed:meshHeadingpubmed-meshheading:11972391...lld:pubmed
pubmed-article:11972391pubmed:meshHeadingpubmed-meshheading:11972391...lld:pubmed
pubmed-article:11972391pubmed:meshHeadingpubmed-meshheading:11972391...lld:pubmed
pubmed-article:11972391pubmed:meshHeadingpubmed-meshheading:11972391...lld:pubmed
pubmed-article:11972391pubmed:meshHeadingpubmed-meshheading:11972391...lld:pubmed
pubmed-article:11972391pubmed:year2002lld:pubmed
pubmed-article:11972391pubmed:articleTitleCellular glutathione content, in vitro chemoresponse, and the effect of BSO modulation in samples derived from patients with advanced ovarian cancer.lld:pubmed
pubmed-article:11972391pubmed:affiliationHaematology Research, Pembury Hospital, Pembury, Tunbridge Wells, Kent TN2 4QJ, United Kingdom.lld:pubmed
pubmed-article:11972391pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11972391pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11972391lld:pubmed